All Stories

  1. Ketamine’s pharmacokinetic and pharmacodynamic interactions with anticonvulsants, and their implications for psychiatry: A scoping review protocol

    Article • February 2023, Cold Spring Harbor Laboratory Press

    Dr Mario F. Juruena

  2. Identifying the neuropsychiatric health effects of low-dose lithium interventions: A systematic review

    Article • Neuroscience & Biobehavioral Reviews, January 2023, Elsevier

    Dr Mario F. Juruena

  3. Oxidative stress and inflammatory process in borderline personality disorder (BPD): a narrative review

    Article • Brazilian Journal of Medical and Biological Research, January 2023, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  4. The Association of Biochemical and Genetic Biomarkers in VEGF Pathway with Depression

    Article • Pharmaceutics, December 2022, MDPI AG

    Dr Mario F. Juruena

  5. Increased immuno-inflammatory mediators in women with post-traumatic stress disorder after sexual assault: 1-Year follow-up

    Article • Journal of Psychiatric Research, November 2022, Elsevier

    Dr Mario F. Juruena

  6. Differential Diagnosis of Major Depressive Disorder and Bipolar Disorder: Genetic and Hormonal Assessment and the Influence of Early-Life Stress

    Article • Brain Sciences, October 2022, MDPI AG

    Dr Mario F. Juruena

  7. Reply to Skokou, M. Comment on “Keeler et al. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients 2021, 13, 4158”

    Article • Nutrients, May 2022, MDPI AG

    Dr Mario F. Juruena

  8. Predictive value of cardiometabolic biomarkers and depressive symptoms for symptom severity and quality of life in patients with psychotic disorders

    Article • Journal of Affective Disorders, February 2022, Elsevier

    Dr Mario F. Juruena

  9. Neuroendocrine and stress pathways in bipolar disorders

    Article • January 2022, Elsevier

    Dr Mario Juruena, Dr Mario F. Juruena

  10. Confirmatory factorial analysis of the Maslach Burnout Inventory – Human Services Survey in health professionals in emergency services

    Article • Revista Latino-Americana de Enfermagem, January 2021, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  11. The pharmacological interaction of compounds in ayahuasca: a systematic review

    Article • Brazilian Journal of Psychiatry, December 2020, FRACTAL EDITORA LTDA

    Dr Mario F. Juruena

  12. Posttraumatic Stress Disorder and Neuroprogression in Women Following Sexual Assault: Protocol for a Randomized Clinical Trial Evaluating Allostatic Load and Aging Process Acceleration

    Article • JMIR Research Protocols, November 2020, JMIR Publications Inc.

    Dr Mario F. Juruena

  13. Efficacy and safety of bright light therapy for bipolar depression

    Article • Psychiatry and Clinical Neurosciences, May 2020, Wiley

    Dr Mario F. Juruena

  14. Posttraumatic stress disorder and neuroprogression: a study protocol of the increase of allostatic load and acceleration of the aging process following trauma (Preprint)

    Article • April 2020, JMIR Publications Inc.

    Dr Mario F. Juruena

  15. The Role of Early Life Stress in HPA Axis and Anxiety

    Article • January 2020, Springer Science + Business Media

    Dr Mario F. Juruena

  16. Has the sun set for seasonal affective disorder and HPA axis studies? A systematic review and future prospects

    Article • Journal of Affective Disorders, September 2019, Elsevier

    Dr Mario F. Juruena

  17. Child Abuse and Neglect as Risk Factors for Comorbidity Between Depression and Chronic Pain in Adulthood

    Article • The Journal of Nervous and Mental Disease, July 2019, Wolters Kluwer Health

    Dr Mario F. Juruena

  18. Relationship Between Depression and Subtypes of Early Life Stress in Adult Psychiatric Patients

    Article • Frontiers in Psychiatry, February 2019, Frontiers

    Dr Mario F. Juruena

  19. Bipolar affective disorder and borderline personality disorder: Differentiation based on the history of early life stress and psychoneuroendocrine measures

    Article • Behavioural Brain Research, January 2019, Elsevier

    Dr Mario F. Juruena, Dr Mario Juruena

  20. Genetic biomarkers for differential diagnosis of major depressive disorder and bipolar disorder: A systematic and critical review

    Article • Behavioural Brain Research, January 2019, Elsevier

    Dr Mario F. Juruena

  21. Childhood Sexual Abuse and Indicators of Immune Activity: A Systematic Review

    Article • Frontiers in Psychiatry, August 2018, Frontiers

    Dr Mario F. Juruena

  22. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review

    Article • Journal of Affective Disorders, June 2018, Elsevier

    Dr Mario F. Juruena

  23. Additional evidence for the classification of a facial expression of anxiety.

    Article • Psychology & Neuroscience, March 2018, American Psychological Association (APA)

    Dr. Vinicius Ferreira Borges, Dr Mario F. Juruena

  24. Is a SIMPLe smartphone application capable of improving biological rhythms in bipolar disorder?

    Article • Journal of Affective Disorders, December 2017, Elsevier

    Dr Mario F. Juruena

  25. The Role of Early Life Stress in HPA Axis and Depression

    Article • October 2017, Springer Science + Business Media

    Dr Mario F. Juruena, Dr Mario Juruena

  26. A translational approach to clinical practice via stress-responsive glucocorticoid receptor signaling

    Article • February 2017, AME Publishing Company

    Dr Mario F. Juruena

  27. Personality disorders

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena

  28. Mental Disorders Diagnostic

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena, Dr Mario Juruena

  29. Pharmacotherapy for general practitioners

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena

  30. Diagnosis of unipolar and bipolar depressions and their specifiers

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena

  31. Trauma and stressor-related disorders

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena, Dr Mario Juruena

  32. Bipolar disorder: a review of conceptual and clinical aspects

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena, Dr. Vinicius Ferreira Borges

  33. Neuropsychological changes in melancholic and atypical depression: A systematic review

    Article • Neuroscience & Biobehavioral Reviews, February 2017, Elsevier

    Dr Mario F. Juruena

  34. Day hospital and psychosocial care center: Expanding the discussion of partial hospitalization in mental health

    Article • Revista da Associação Médica Brasileira, July 2016, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  35. Burnout in nursing professionals: Associations with early stress

    Article • British Journal of Mental Health Nursing, November 2015, Mark Allen Group

    Dr Mario F. Juruena

  36. Early Life Stress in Depressive Patients: Role of Glucocorticoid and Mineralocorticoid Receptors and of Hypothalamic-Pituitary-Adrenal Axis Activity

    Article • Current Pharmaceutical Design, February 2015, Bentham Science Publishers

    Dr Mario F. Juruena

  37. Factors related to the cortisol awakening response of children working on the streets and siblings, before and after 2 years of a psychosocial intervention

    Article • Psychiatry Research, February 2015, Elsevier

    Dr Mario F. Juruena

  38. INCLUSION OF PATIENTS OF A MENTAL HEALTH DAY HOSPITAL: A REVIEW

    Article • Psicologia Saúde & Doença, November 2014, Sociedad Portuguesa de Psicologia da Saude

    Dr Mario F. Juruena

  39. Emotional Abuse in Childhood Is a Differential Factor for the Development of Depression in Adults

    Article • The Journal of Nervous and Mental Disease, November 2014, Wolters Kluwer Health

    Dr Mario F. Juruena

  40. P.2.b.040 MR and GR balance predicts treatment outcome in treatment resistant depression

    Article • European Neuropsychopharmacology, October 2014, Elsevier

    Dr Mario F. Juruena

  41. Early-life stress and HPA axis trigger recurrent adulthood depression

    Article • Epilepsy & Behavior, September 2014, Elsevier

    Dr Mario F. Juruena, Dr Mario Juruena

  42. Avaliação do funcionamento do eixo HPA em deprimidos por meio de medidas basais: revisão sistemática da literatura e análise das metodologias utilizadas

    Article • Jornal Brasileiro de Psiquiatria, September 2014, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  43. Long-term symptomatic and functional outcome following an intensive inpatient multidisciplinary intervention for treatment-resistant affective disorders

    Article • Journal of Affective Disorders, September 2014, Elsevier

    Dr Mario F. Juruena

  44. Early Life Stress in Depressive Patients: HPA Axis Response to GR and MR Agonist

    Article • Frontiers in Psychiatry, January 2014, Frontiers

    Dr Mario F. Juruena

  45. The impact of childhood adversity on suicidality and clinical course in treatment-resistant depression

    Article • Journal of Affective Disorders, January 2014, Elsevier

    Dr Mario F. Juruena

  46. The Role of Early Life Stress in Adult Psychiatric Disorders

    Article • The Journal of Nervous and Mental Disease, December 2013, Wolters Kluwer Health

    Dr Mario F. Juruena

  47. P.2.b.050 Mineralocorticoid receptor function a predictor of treatment response in depression with or without early life stress

    Article • European Neuropsychopharmacology, October 2013, Elsevier

    Dr Mario F. Juruena

  48. Pharmacological and Psychosocial Management of Mental, Neurological and Substance Use Disorders in Low- and Middle-Income Countries: Issues and Current Strategies

    Article • Drugs, September 2013, Springer Science + Business Media

    Dr Mario F. Juruena

  49. The role of mineralocorticoid receptor function in treatment-resistant depression

    Article • Journal of Psychopharmacology, July 2013, SAGE Publications

    Dr Mario F. Juruena

  50. Effectiveness of psychoeducation for depression: A systematic review

    Article • Australian & New Zealand Journal of Psychiatry, June 2013, SAGE Publications

    Dr Mario F. Juruena

  51. Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system

    Article • Journal of Affective Disorders, May 2013, Elsevier

    Dr Mario F. Juruena

  52. An exploratory dimensional approach to premenstrual manifestation of obsessive–compulsive disorder symptoms: A multicentre study

    Article • Journal of Psychosomatic Research, April 2013, Elsevier

    Dr Mario F. Juruena

  53. 2204 – Differential diagnosis between bipolar disorder and borderline personality disorder based on early life stress and psychoneuroendocrine assessment

    Article • European Psychiatry, January 2013, Elsevier

    Dr Mario F. Juruena

  54. Antipsychotic agents: efficacy and safety in schizophrenia

    Article • Drug Healthcare and Patient Safety, November 2012, Taylor & Francis

    Dr Mario F. Juruena, Dr Arão Araújo, Irismar Reis de Oliveira, Dr Mario Juruena

  55. Plasma cortisol in first episode drug-naïve mania: Differential levels in euphoric versus irritable mood

    Article • Journal of Affective Disorders, April 2012, Elsevier

    Dr Mario F. Juruena

  56. Cognitive-Behavioral Therapy for the Bipolar Disorder Patients

    Article • March 2012, IntechOpen

    Dr Mario F. Juruena, Dr Mario Juruena

  57. Clinical, Research and Treatment Approaches to Affective Disorders

    Article • February 2012, IntechOpen

    Dr Mario F. Juruena, Dr Mario Juruena

  58. Assessment of the hypothalamic–pituitary–adrenal axis activity: glucocorticoid receptor and mineralocorticoid receptor function in depression with early life stress – a systematic review

    Article • Acta Neuropsychiatrica, February 2012, Cambridge University Press

    Dr Mario F. Juruena

  59. Effects of lithium on oxidative stress parameters in healthy subjects

    Article • Molecular Medicine Reports, December 2011, Spandidos Publications

    Dr Mario F. Juruena

  60. P.2.c.030 The role of mineralocorticoid receptor function in treatment resistant depression M.F. Juruena

    Article • European Neuropsychopharmacology, September 2011, Elsevier

    Dr Mario F. Juruena

  61. Specific mechanism of action of amisulpride in the treatment of schizophrenia and correlation with clinical response and tolerability

    Article • Journal of Receptor Ligand and Channel Research, August 2011, Taylor & Francis

    Dr Mario F. Juruena, Irismar Reis de Oliveira

  62. An integrative science approach: neuroscience in the DSM-V and ICD-11.

    Article • Acta Neuropsychiatrica, August 2011, Cambridge University Press

    Dr Mario F. Juruena

  63. Efficacy of psychoeducation in bipolar patients: Systematic review of randomized trials.

    Article • Psychology & Neuroscience, July 2011, American Psychological Association (APA)

    Dr Mario F. Juruena

  64. Prospective evaluation of specialist inpatient treatment for refractory affective disorders

    Article • Journal of Affective Disorders, June 2011, Elsevier

    Dr Mario F. Juruena

  65. Latin American Studies in Melancholia

    Article • Brazilian Journal of Psychiatry, May 2011, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  66. Evaluation of hippocampal volume based on MR imaging in patients with bipolar affective disorder applying manual and automatic segmentation techniques

    Article • Journal of Magnetic Resonance Imaging, February 2011, Wiley

    Dr Mario F. Juruena

  67. Early life stress, HPA axis, and depression.

    Article • Psychology & Neuroscience, January 2011, American Psychological Association (APA)

    Dr Mario F. Juruena

  68. Analysis of the occurrence of early life stress in adult psychiatric patients: A systematic review.

    Article • Psychology & Neuroscience, January 2011, American Psychological Association (APA)

    Dr Mario F. Juruena

  69. Sertindole in the Management of Schizophrenia

    Article • Journal of Central Nervous System Disease, January 2011, SAGE Publications

    Dr Mario F. Juruena

  70. The prednisolone suppression test in depression: Dose–response and changes with antidepressant treatment

    Article • Psychoneuroendocrinology, November 2010, Elsevier

    Dr Mario F. Juruena

  71. Safety and tolerability of antipsychotics: focus on amisulpride

    Article • Drug Healthcare and Patient Safety, October 2010, Taylor & Francis

    Dr Mario F. Juruena, Irismar Reis de Oliveira, Dr Mario Juruena

  72. P.2.a.031 Prednisolone suppression test, but not dexamethasone predicts outcome in treatment resistant depression

    Article • European Neuropsychopharmacology, August 2010, Elsevier

    Dr Mario F. Juruena

  73. Longer-term outcome of treatment resistant depression after specialist, multimodal, inpatient treatment: A prospective follow up study

    Article • Journal of Affective Disorders, April 2010, Elsevier

    Dr Mario F. Juruena

  74. Amygdala activation to masked happy facial expressions

    Article • Journal of the International Neuropsychological Society, December 2009, Cambridge University Press

    Professor Cynthia H.Y, Fu, Dr Mario F. Juruena

  75. In vivo evaluation of cortical thickness with magnetic resonance imaging in patients with bipolar disorder

    Article • Psicologia Teoria e Pesquisa, December 2009, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  76. Exposição ao chumbo: consequências neuropsiquiátricas e comportamentais

    Article • Medicina (Ribeirão Preto), September 2009, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena

  77. P.2.b.014 Four days of citalopram increase in vitro glucocorticoid receptor function in healthy volunteers

    Article • European Neuropsychopharmacology, September 2009, Elsevier

    Dr Mario F. Juruena

  78. In vivo evaluation of cortical thickness with magnetic resonance imaging in patients with bipolar disorder.

    Article • Psychology & Neuroscience, July 2009, American Psychological Association (APA)

    Dr Mario F. Juruena

  79. Reply: ‘Clomipramine and Glucocorticoid Receptor Function’

    Article • Neuropsychopharmacology, May 2009, Nature

    Dr Mario F. Juruena

  80. Revisão das diretrizes da Associação Médica Brasileira para o tratamento da depressão (Versão integral)

    Article • Brazilian Journal of Psychiatry, May 2009, FapUNIFESP (SciELO)

    Dr Marcelo Berlim, Dr Mario F. Juruena

  81. Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance

    Article • The British Journal of Psychiatry, March 2009, Royal College of Psychiatrists

    Dr Mario F. Juruena

  82. Bipolar I and II disorder residual symptoms: Oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, February 2009, Elsevier

    Dr Mario F. Juruena

  83. The ratio of cortisol/DHEA in treatment resistant depression

    Article • Psychoneuroendocrinology, January 2009, Elsevier

    Dr Mario F. Juruena

  84. Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series

    Article • Journal of Psychopharmacology, June 2008, SAGE Publications

    Dr Mario F. Juruena, Dr Mario Juruena

  85. Clomipramine In Vitro Reduces Glucocorticoid Receptor Function in Healthy Subjects but not in Patients with Major Depression

    Article • Neuropsychopharmacology, March 2008, Nature

    Dr Mario F. Juruena

  86. S.07.05 Prednisolone suppression test as a predictor of outcome in treatment resistant depression

    Article • European Neuropsychopharmacology, October 2007, Elsevier

    Dr Mario F. Juruena

  87. P.2.a.033 Treatment resistant depression: prednisolone suppression test predicts response to inpatient treatment

    Article • European Neuropsychopharmacology, October 2007, Elsevier

    Dr Mario F. Juruena

  88. Um paradigma para entender e tratar as doenças psiquiátricas

    Article • Brazilian Journal of Psychiatry, May 2007, FRACTAL EDITORA LTDA

    Dr Mario F. Juruena

  89. Superposição entre depressão atípica, doença afetiva sazonal e síndrome da fadiga crônica

    Article • Brazilian Journal of Psychiatry, May 2007, FRACTAL EDITORA LTDA

    Dr Mario F. Juruena

  90. Depressão e estresse: existe um endofenótipo?

    Article • Brazilian Journal of Psychiatry, May 2007, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  91. P.3.18 Prednisolone suppression test as a predictor of outcome in treatment resistant depression

    Article • European Neuropsychopharmacology, March 2007, Elsevier

    Dr Mario F. Juruena

  92. Treatment of psychosis: 30 years of progress

    Article • Journal of Clinical Pharmacy and Therapeutics, November 2006, Wiley

    Dr Mario F. Juruena

  93. Different responses to dexamethasone and prednisolone in the same depressed patients

    Article • Psychopharmacology, October 2006, Springer Science + Business Media

    Dr Mario F. Juruena

  94. Glucocorticoid sensitivity in whole blood cells from healthy volunteers: effect of antidepressants

    Article • European Neuropsychopharmacology, January 2006, Elsevier

    Dr Mario F. Juruena

  95. P.2.a.003 Treatment resistant depression: response to prednisolone supression test

    Article • European Neuropsychopharmacology, January 2006, Elsevier

    Dr Mario F. Juruena

  96. P.4.10 Different response to a dexamethasone and prednisolone test in treatment-resistant depressed patients

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Dr Mario F. Juruena

  97. Distimia: características históricas e nosológicas e sua relação com transtorno depressivo maior

    Article • Revista de Psiquiatria do Rio Grande do Sul, December 2004, FapUNIFESP (SciELO)

    Dr Lucas Spanemberg , Dr Mario F. Juruena

  98. O eixo hipotálamo-pituitária-adrenal, a função dos receptores de glicocorticóides e sua importância na depressão

    Article • Brazilian Journal of Psychiatry, September 2004, FRACTAL EDITORA LTDA

    Dr Mario F. Juruena

  99. Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders

    Article • Acta Neuropsychiatrica, December 2003, Cambridge University Press

    Dr Mario F. Juruena

  100. Diretrizes da Associação Médica Brasileira para o tratamento da depressão (versão integral)

    Article • Brazilian Journal of Psychiatry, June 2003, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  101. Lithium reduces maternal child abuse behaviour: a preliminary report

    Article • Journal of Clinical Pharmacy and Therapeutics, August 2001, Wiley

    Dr Mario F. Juruena

  102. Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia

    Article • Journal of Psychopharmacology, January 2000, SAGE Publications

    Dr Mario F. Juruena

  103. Confiabilidade diagnóstica dos transtornos mentais da versão para cuidados primários da Classificação Internacional das Doenças

    Article • Revista de Saúde Pública, October 1999, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  104. The role of depression in coronary artery disease

    Article • Arquivos Brasileiros de Cardiologia, August 1999, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  105. Moclobemide effects on prolactin plasma levels in healthy individuals

    Article • International Clinical Psychopharmacology, November 1997, Wolters Kluwer Health

    Dr Mario F. Juruena

  106. Abstracts and Reviews : 2. South America

    Article • Transcultural Psychiatric Research Review, January 1992, SAGE Publications

    Dr Mario F. Juruena

  107. Bergara, Dr Mario

    Article • De Gruyter

    Dr Mario F. Juruena